L N Maslov Selected Research

L N Maslov Research Topics

Disease

73	Ischemia 04/2021 - 02/2000
32	Infarction (Infarctions) 05/2022 - 01/2001
24	Hypoxia (Hypoxemia) 12/2020 - 01/2003
19	Reperfusion Injury 01/2021 - 02/2000
17	Coronary Occlusion 07/2017 - 06/2001
11	Myocardial Infarction 12/2020 - 02/2002
8	Ventricular Fibrillation 01/2006 - 01/2001
8	Cardiac Arrhythmias (Arrythmia) 11/2004 - 03/2000
5	Necrosis 12/2020 - 02/2002
5	Hypertrophy 01/2016 - 08/2012
4	Bradycardia 01/2021 - 12/2005
4	Heart Injuries 01/2019 - 03/2005
3	Cardiomyopathies (Cardiomyopathy) 01/2019 - 01/2013
3	Diabetes Mellitus 01/2017 - 01/2007
3	Contracture 01/2008 - 04/2001
3	Coronary Disease (Coronary Heart Disease) 01/2007 - 01/2002
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2017 - 01/2002
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 01/2017
2	Atherosclerosis 01/2017 - 09/2002
2	Stomach Ulcer (Gastric Ulcer) 01/2016 - 08/2015
2	Cardiomegaly (Heart Hypertrophy) 05/2015 - 10/2013
2	Hypertension (High Blood Pressure) 05/2015 - 10/2013
2	No-Reflow Phenomenon 01/2014 - 01/2010
2	Ganglion Cysts (Ganglion) 04/2006 - 05/2001

Drug/Important Bio-Agent (IBA)

31	Opioid Receptors (Opioid Receptor)IBA 04/2021 - 05/2001
16	Adenosine Triphosphate (ATP)IBA 05/2022 - 09/2001
16	Opioid Analgesics (Opioids)IBA 04/2021 - 02/2000
12	HU 211 (HU 210)IBA 11/2016 - 05/2001
11	D-Penicillamine (2,5)- EnkephalinIBA 03/2021 - 01/2002
10	Creatine Kinase (Creatine Phosphokinase)IBA 12/2020 - 09/2001
9	SolutionsIBA 04/2020 - 11/2000
8	CannabinoidsIBA 01/2017 - 05/2001
8	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2017 - 06/2001
8	Ala(2)-Arg(6)- enkephalin-LeuIBA 06/2008 - 01/2002
8	delta Opioid Receptors (delta Opioid Receptor)IBA 10/2006 - 09/2000
7	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2021 - 01/2001
6	Ala(2)- deltorphin IIIBA 05/2022 - 11/2005
6	ChloraloseIBA 03/2021 - 06/2001
6	KATP ChannelsIBA 05/2017 - 09/2001
6	LigandsIBA 01/2017 - 03/2000
6	Proteins (Proteins, Gene)FDA Link 01/2013 - 05/2010
5	Narcotic Antagonists (Opioid Antagonists)IBA 04/2021 - 01/2003
5	Naltrexone (ReVia)FDA LinkGeneric 04/2021 - 06/2008
5	mu Opioid Receptors (mu Opioid Receptor)IBA 03/2008 - 04/2001
5	sigma Receptors (sigma Receptor)IBA 03/2004 - 03/2000
4	Protein Kinase CIBA 05/2022 - 06/2009
4	tyrosyl- tetrahydroisoquinolinecarbonyl- psi(methylamino)phenylalanyl- phenylalanineIBA 01/2021 - 01/2003
4	Phosphotransferases (Kinase)IBA 12/2020 - 01/2013
4	ORALIT (ORS)IBA 12/2019 - 11/2003
4	Hexamethonium (Hexamethonium Bromide)IBA 07/2017 - 05/2001
4	CB2 Cannabinoid ReceptorIBA 01/2017 - 05/2002
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 08/2011
4	Adenosine (Adenocard)FDA LinkGeneric 01/2016 - 01/2010
4	Peptides (Polypeptides)IBA 01/2015 - 01/2002
3	(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA 04/2021 - 12/2009
3	naltrindole benzofuranIBA 03/2021 - 06/2016
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019 - 06/2015
3	RimonabantIBA 01/2017 - 05/2001
3	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2016 - 10/2013
3	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 10/2015 - 02/2000
3	CatecholaminesIBA 05/2015 - 04/2003
3	BradykininIBA 01/2015 - 04/2011
3	Erythropoietin FDA Link 01/2013 - 09/2006
3	Nociceptin ReceptorIBA 06/2009 - 11/2004
3	Pharmaceutical PreparationsIBA 05/2008 - 01/2007
3	methanandamideIBA 01/2007 - 02/2002
3	anandamide (arachidonylethanolamide)IBA 01/2007 - 02/2002
3	tyrosyl-arginyl-phenylalanyl-lysinamide (DALDA)IBA 11/2003 - 09/2001
3	Thr(6)- Leu(5) Ser(2) enkephalinIBA 07/2003 - 02/2000
2	norbinaltorphimineIBA 03/2021 - 01/2021
2	N-methylnaloxoneIBA 03/2021 - 01/2021
2	ICI 199441IBA 01/2021 - 10/2015
2	Protein Kinases (Protein Kinase)IBA 12/2020 - 09/2011
2	Oxygen (Dioxygen)IBA 12/2019 - 01/2002
2	Naloxone (Narcan)FDA LinkGeneric 01/2019 - 06/2016
2	Glyburide (Glibenclamide)FDA LinkGeneric 05/2017 - 10/2010
2	LipidsIBA 01/2017 - 01/2002
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2016 - 01/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016 - 08/2015
2	Nitric Oxide Synthase (NO Synthase)IBA 08/2015 - 02/2002
2	mitochondrial K(ATP) channelIBA 06/2015 - 05/2013
2	Angiotensin IIIBA 05/2015 - 10/2013
2	AldosteroneIBA 05/2015 - 10/2013
2	Endothelins (Endothelin)IBA 05/2015 - 10/2013
2	Thyroid HormonesIBA 05/2015 - 10/2013
2	Purinergic P1 Receptor AgonistsIBA 01/2014 - 01/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 09/2006
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2013 - 09/2006
2	Cyclic NucleotidesIBA 12/2009 - 05/2008
2	kappa(1) opioid receptorIBA 09/2008 - 03/2008
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 07/2008 - 05/2001
2	SR 144528IBA 07/2008 - 10/2006

Therapy/Procedure

7	Intravenous Administration 03/2008 - 07/2002
6	Transplantation 01/2016 - 01/2006
4	Ischemic Postconditioning 07/2016 - 01/2012
3	Intravenous Injections 07/2017 - 06/2001
3	Intravenous Infusions 01/2016 - 12/2005
2	Ligation 11/2017 - 11/2005
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2016 - 01/2013
2	Stents 01/2007 - 01/2007